Zero Candida Technologies Inc. stock analysis
Zero Candida Technologies Inc. (ZCT) Stock Price & Analysis
ZCT Stock Chart & Stats
- Day’s Range
- CAD 0.11 - CAD 0.11
- 52-Week Range
- CAD 0.11 - CAD 0.28
- Previous Close
- CAD 0.11
- Volume
- N/A
- Average Volume (3M)
- 1,117
- Market Cap
- CAD 1.13M
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- CAD 0
- Price to Earnings (P/E)
- ―
- Beta
- 0.19
- Next Earnings
- Nov 26, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Zero Candida Technologies Inc. News
ZCT FAQ
What was Zero Candida Technologies Inc.’s price range in the past 12 months?
What is Zero Candida Technologies Inc.’s market cap?
When is Zero Candida Technologies Inc.’s upcoming earnings report date?
Is Zero Candida Technologies Inc. overvalued?
Does Zero Candida Technologies Inc. pay dividends?
What is Zero Candida Technologies Inc.’s EPS estimate?
How many shares outstanding does Zero Candida Technologies Inc. have?
Which hedge fund is a major shareholder of Zero Candida Technologies Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Zero Candida Technologies Inc.
Zero Candida is focused on commercial exploitation of a number of patents and patent applications with respect to an AI smart tampon-like device, designed to treat Candidiasis and transfer the medical information via Wi-Fi to the doctor. ZC technology is a combination of a therapy light source with a selected wavelength and intensity and a transparent gel-based drug delivery system to maintain the optimum Ph level in the vagina. The device when used overnight, demonstrated a 99.9999% Candidiasis elimination in the vagina within 3 nights. ZC developed a first prototype of its device in May of 2022 and immediately commenced its first laboratory tests as a "proof of concept". In September 2023 ZC completed its pre-clinical animal studies and subsequently developed a protype (1st series) and commenced its validation. ZC is currently in the process of developing the design of its device and continues pre-clinical animal studies.
- Sector
- General
- Industry
- Medical Equipment & Supplies
- CEO
- Eli Ben-Haroosh
- Employees
- 0
- Website
- zero-candida.com/
- Address
- c/o Tanya Markovich Law Corporation,Suite 500 - 666 Burrard Street, Vancouver, British Columbia, V6C 3P6, CA
Zero Candida Technologies Inc. (ZCT) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 2 | 16 |
| Technical Analysis | 4 | 2 | 4 |
| Moving Averages | 0 | 0 | 12 |






